Authors:
GASTER LM
BLANEY FE
DAVIES S
DUCKWORTH DM
HAM P
JENKINS S
JENNINGS AJ
JOINER GF
KING FD
MULHOLLAND KR
WYMAN PA
HAGAN JJ
HATCHER J
JONES BJ
MIDDLEMISS DN
PRICE GW
RILEY G
ROBERTS C
ROUTLEDGE C
SELKIRK J
SLADE PD
Citation: Lm. Gaster et al., THE SELECTIVE 5-HT1B RECEPTOR INVERSE AGONIST TETRAHYDROSPIRO[FURO[2,3-F]INDOLE-3,4'-PIPERIDINE] (SB-224289) POTENTLY BLOCKS TERMINAL 5-HT AUTORECEPTOR FUNCTION BOTH IN-VITRO AND IN-VIVO, Journal of medicinal chemistry, 41(8), 1998, pp. 1218-1235
Authors:
BROMIDGE SM
DABBS S
DAVIES DT
DUCKWORTH DM
FORBES IT
HAM P
JONES GE
KING FD
SAUNDERS DV
STARR S
THEWLIS KM
WYMAN PA
BLANEY FE
NAYLOR CB
BAILEY F
BLACKBURN TP
HOLLAND V
KENNETT GA
RILEY GJ
WOOD MD
Citation: Sm. Bromidge et al., NOVEL AND SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS AS POTENTIAL ANXIOLYTIC AGENTS - SYNTHESIS, QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS, AND MOLECULAR MODELING OF SUBSTITUTED 1-(3-PYRIDYLCARBAMOYL)INDOLINES/, Journal of medicinal chemistry, 41(10), 1998, pp. 1598-1612
Authors:
BROMIDGE SM
DUCKWORTH M
FORBES IT
HAM P
KING FD
THEWLIS KM
BLANEY FE
NAYLOR CB
BLACKBURN TP
KENNETT GA
WOOD MD
CLARKE SE
Citation: Sm. Bromidge et al., ETHYL-3-PYRIDYL)OXY]-5-PYRIDYL]CARBAMOYL]-INDOLINE (SB-242084) - THE FIRST SELECTIVE AND BRAIN PENETRANT 5-HT2C RECEPTOR ANTAGONIST, Journal of medicinal chemistry, 40(22), 1997, pp. 3494-3496
Authors:
FORBES IT
DABBS S
DUCKWORTH DM
HAM P
JONES GE
KING FD
SAUNDERS DV
BLANEY FE
NAYLOR CB
BAXTER GS
BLACKBURN TP
KENNETT GA
WOOD MD
Citation: It. Forbes et al., SYNTHESIS, BIOLOGICAL-ACTIVITY, AND MOLECULAR MODELING STUDIES OF SELECTIVE 5-HT2C 2B RECEPTOR ANTAGONISTS/, Journal of medicinal chemistry, 39(25), 1996, pp. 4966-4977
Citation: Fe. Blaney et al., MOLECULAR-SURFACE COMPARISON .2. SIMILARITY OF ELECTROSTATIC VECTOR-FIELDS IN DRUG DESIGN, Journal of molecular graphics, 13(3), 1995, pp. 165-174